Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies

Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies

Background:Rapid drug desensitization (RDD) allows first-line therapies in patients with immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD) and monoclonal antibodies (mAb). Desensitization in delayed drug reactions has traditionally used slow protocols extending up to se...

Full description

Bibliographic Details
Main Authors: Arantza Vega, M. Isabel Peña, Inés Torrado
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Allergy
Subjects:
rapid drug desensitization
desensitization
chemotherapeutic drugs
monoclonal antibodies
delayed drug reactions
no-immediate drug reactions
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2021.786863/full

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2021.786863/full

Similar Items